• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外基质硬度通过破坏P53与CDKN1A启动子的结合降低DNA 6mA水平,以促进结直肠癌进展。

Extracellular matrix stiffness reduces DNA 6 ma level to facilitate colorectal cancer progression via disrupting P53 binding to CDKN1A promoter.

作者信息

Xie Si-An, Li Xue, Yin Min-Yue, Du Feng, Zhang Shu-Tian, Zhu Sheng-Tao

机构信息

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, State Key Laboratory of Digestive Health, Beijing, 100050, China.

出版信息

Exp Hematol Oncol. 2025 Aug 27;14(1):111. doi: 10.1186/s40164-025-00704-w.

DOI:10.1186/s40164-025-00704-w
PMID:40867005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12382035/
Abstract

The extracellular matrix (ECM) forms the primary scaffold of the tumor microenvironment, with matrix stiffness serving as a critical physical cue that modulates cancer progression. However, the impact of matrix stiffness on colorectal cancer (CRC) progression remains elusive. This study aimed to elucidate the role of substrate stiffness in regulating DNA N6-methyladenine (6 mA) modifications and their association with CRC progression. We observed significantly reduced DNA 6 mA levels in CRC cells and tissues compared to normal controls, which progressively declined with advancing CRC stages. A negative correlation was identified between CRC tissue stiffness and DNA 6 mA levels. The 6 mA demethylase ALKBH1 was identified as a poor prognostic indicator in CRC and responded to increased substrate stiffness, correlating with enhanced CRC proliferation. Mechanistically, ALKBH1 mediated DNA 6 mA demethylation in response to substrate stiffening, thereby modulating gene transcription and promoting CRC tumorigenesis. Notably, ALKBH1 lost its proliferative effect in P53-knockout CRC cells, while a catalytically inactive ALKBH1 mutant suppressed oncogenesis. Furthermore, ALKBH1 diminished CDKN1A expression by impairing P53 binding to the CDKN1A promoter region. Collectively, our findings demonstrate that ALKBH1 acts as a pivotal mediator linking matrix stiffness to DNA 6 mA demethylation, critically driving CRC progression and highlighting its therapeutic potential. These results underscore the importance of DNA 6 mA modifications in CRC development and tumor response to microenvironmental cues.

摘要

细胞外基质(ECM)构成肿瘤微环境的主要支架,基质硬度作为一种关键的物理信号,调节癌症进展。然而,基质硬度对结直肠癌(CRC)进展的影响仍不清楚。本研究旨在阐明底物硬度在调节DNA N6-甲基腺嘌呤(6mA)修饰及其与CRC进展关联中的作用。我们观察到,与正常对照相比,CRC细胞和组织中的DNA 6mA水平显著降低,且随着CRC分期的推进而逐渐下降。CRC组织硬度与DNA 6mA水平之间存在负相关。6mA去甲基化酶ALKBH1被确定为CRC的不良预后指标,并对增加的底物硬度作出反应,与CRC增殖增强相关。机制上,ALKBH1响应底物硬化介导DNA 6mA去甲基化,从而调节基因转录并促进CRC肿瘤发生。值得注意的是,ALKBH1在P53基因敲除的CRC细胞中失去其增殖作用,而催化失活的ALKBH1突变体抑制肿瘤发生。此外,ALKBH1通过损害P53与CDKN1A启动子区域的结合来降低CDKN1A的表达。总体而言,我们的研究结果表明,ALKBH1作为连接基质硬度与DNA 6mA去甲基化的关键介质,严重驱动CRC进展并突出其治疗潜力。这些结果强调了DNA 6mA修饰在CRC发展和肿瘤对微环境信号反应中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/9597676cb4b6/40164_2025_704_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/3e0737855324/40164_2025_704_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/c0ccd330d9f9/40164_2025_704_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/bd742d771cbb/40164_2025_704_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/f0da68c61fda/40164_2025_704_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/9712fb866b30/40164_2025_704_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/27ab280e2bc0/40164_2025_704_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/a337455c7632/40164_2025_704_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/9597676cb4b6/40164_2025_704_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/3e0737855324/40164_2025_704_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/c0ccd330d9f9/40164_2025_704_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/bd742d771cbb/40164_2025_704_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/f0da68c61fda/40164_2025_704_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/9712fb866b30/40164_2025_704_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/27ab280e2bc0/40164_2025_704_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/a337455c7632/40164_2025_704_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/430d/12382035/9597676cb4b6/40164_2025_704_Fig8_HTML.jpg

相似文献

1
Extracellular matrix stiffness reduces DNA 6 ma level to facilitate colorectal cancer progression via disrupting P53 binding to CDKN1A promoter.细胞外基质硬度通过破坏P53与CDKN1A启动子的结合降低DNA 6mA水平,以促进结直肠癌进展。
Exp Hematol Oncol. 2025 Aug 27;14(1):111. doi: 10.1186/s40164-025-00704-w.
2
To investigate the tumor promotion role of PLOD3 in colorectal cancer and its potential as a prognostic biomarker and therapeutic target.探讨PLOD3在结直肠癌中的肿瘤促进作用及其作为预后生物标志物和治疗靶点的潜力。
Sci Rep. 2025 Feb 13;15(1):5371. doi: 10.1038/s41598-025-89521-z.
3
Potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysis.鞘氨醇激酶1作为结直肠癌预后标志物和治疗靶点的潜力:来自生物信息学和实验分析的见解
Int J Surg. 2025 Jun 24. doi: 10.1097/JS9.0000000000002506.
4
USP6NL knockdown suppresses colorectal cancer progression by inducing CASP9-Mediated apoptosis and disrupting FOXC2/SNAI1-Driven EMT and angiogenesis.USP6NL基因敲低通过诱导半胱天冬酶9介导的凋亡以及破坏FOXC2/SNAI1驱动的上皮-间质转化和血管生成来抑制结直肠癌进展。
Funct Integr Genomics. 2025 Jul 11;25(1):153. doi: 10.1007/s10142-025-01663-5.
5
Proteomic profiling identifies a stromal TGF-β1/podoplanin axis as a driver of colorectal cancer progression.蛋白质组学分析确定基质转化生长因子-β1/血小板内皮细胞黏附分子轴是结直肠癌进展的驱动因素。
J Exp Clin Cancer Res. 2025 Aug 22;44(1):247. doi: 10.1186/s13046-025-03496-3.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Curcumin protects extracellular matrix to maintain microenvironmental stability inhibiting colon cancer metastasis through HPSE/IL-6/STAT5 axis.姜黄素通过HPSE/IL-6/STAT5轴保护细胞外基质以维持微环境稳定性,从而抑制结肠癌转移。
Naturwissenschaften. 2025 Jun 4;112(4):47. doi: 10.1007/s00114-025-01988-y.
8
Ultrasound-targeted microbubble destruction mediated upregulation of CNN1 induces ferroptosis in colorectal cancer cells by regulating p53-related SLC7A11 expression.超声靶向微泡破坏介导的CNN1上调通过调节p53相关的SLC7A11表达诱导结肠癌细胞铁死亡。
Biochem Biophys Res Commun. 2025 Sep 1;777:152207. doi: 10.1016/j.bbrc.2025.152207. Epub 2025 Jun 13.
9
MicroRNA 195, lactate dehydrogenase 5, phosphatase and tensin homologue in colorectal cancer: Clinicopathology and prognosis.微小RNA 195、乳酸脱氢酶5、磷酸酶和张力蛋白同源物在结直肠癌中的临床病理特征及预后分析
World J Gastrointest Surg. 2025 Jul 27;17(7):107121. doi: 10.4240/wjgs.v17.i7.107121.
10
Matrix stiffness-dependent PD-L2 deficiency improves SMYD3/xCT-mediated ferroptosis and the efficacy of anti-PD-1 in HCC.基质硬度依赖性PD-L2缺陷改善SMYD3/xCT介导的铁死亡及抗PD-1在肝癌中的疗效。
J Adv Res. 2025 Jul;73:265-282. doi: 10.1016/j.jare.2024.08.021. Epub 2024 Aug 17.

本文引用的文献

1
Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer.细胞外基质硬度:肿瘤进展机制及癌症治疗潜力
Exp Hematol Oncol. 2025 Apr 10;14(1):54. doi: 10.1186/s40164-025-00647-2.
2
Extracellular matrix stiffness regulates colorectal cancer progression via HSF4.细胞外基质硬度通过热休克因子4调节结直肠癌进展。
J Exp Clin Cancer Res. 2025 Jan 30;44(1):30. doi: 10.1186/s13046-025-03297-8.
3
Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications.
肿瘤微环境中的生物力学:从生物学功能到潜在临床应用
Exp Hematol Oncol. 2025 Jan 11;14(1):4. doi: 10.1186/s40164-024-00591-7.
4
The dysadherin/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression.黏着斑失活蛋白/MMP9 轴改变细胞外基质从而加速结直肠癌进展。
Nat Commun. 2024 Nov 30;15(1):10422. doi: 10.1038/s41467-024-54920-9.
5
Structural Optimization and Structure-Activity Relationship of 1-Pyrazole-4-carboxylic Acid Derivatives as DNA 6mA Demethylase ALKBH1 Inhibitors and Their Antigastric Cancer Activity.1-吡唑-4-羧酸衍生物作为 DNA 6mA 去甲基酶 ALKBH1 抑制剂的结构优化及构效关系及其抗胃癌活性。
J Med Chem. 2024 Sep 12;67(17):15456-15475. doi: 10.1021/acs.jmedchem.4c01072. Epub 2024 Sep 3.
6
Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids.工程化基质揭示了源自患者的胰腺癌细胞类器官中刚度介导的化疗耐药性。
Nat Mater. 2024 Aug;23(8):1138-1149. doi: 10.1038/s41563-024-01908-x. Epub 2024 Jul 4.
7
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
8
Therapeutic targeting of DNA methylation alterations in cancer.癌症中 DNA 甲基化改变的治疗靶向。
Pharmacol Ther. 2024 Jun;258:108640. doi: 10.1016/j.pharmthera.2024.108640. Epub 2024 Apr 1.
9
Discovery of a Potent and Cell-Active Inhibitor of DNA 6mA Demethylase ALKBH1.发现一种有效的、具有细胞活性的 DNA 6mA 去甲基化酶 ALKBH1 抑制剂。
J Am Chem Soc. 2024 Mar 13;146(10):6992-7006. doi: 10.1021/jacs.4c00194. Epub 2024 Mar 4.
10
Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases.基质硬度触发肿瘤和基质细胞之间的脂质代谢串扰,介导结直肠癌肝转移中贝伐珠单抗耐药。
Cancer Res. 2023 Nov 1;83(21):3577-3592. doi: 10.1158/0008-5472.CAN-23-0025.